Thuja
Thuja
Thuja Capital invests in early stage medical product innovations
- Use:
 - Date closing: -
 - Amount: -
 - Industry focus: All
 - Total budget: 34M €
 - Entity type: Venture Capital
 - Vertical focus: biotech, nutraceuticals, medtech and digital health
 - Website: https://www.thujacapital.com/
 
- Status: Open
 - Funding type: Equity investment;
 - Geographic focus:
 - Public/Private: Private
 - Stage focus: Seed; Series A;
 - Applicant target: Startup;
 
Overview
Thuja Capital typically invests in private healthcare companies in the space of biotech, nutraceuticals, medtech and digital health. Often these companies have a specific product that requires clinical validation and is defendable. Thuja values credible business models with a global reach.
They invest in healthcare innovation, from start-up to scale-up.
Thuja Capital has raised a total of €53.2M across 2 funds, their latest being Thuja Capital Healthcare Fund II. This fund was announced on Jun 15, 2016 and raised a total of €34M.
Portfolio: Alveron, Mellon Medical, Atromedical, Indigo.
                    Last updated on 2023-05-19 12:42
                
            Thuja FAQ
            0 questions
        
        
    Thuja Reviews
            0 reviews
        
        Recommend to a Friend
Experience
No data experience
Getting the funds
No data getting funds
Simple process
0 Average
                            Thuja News
Featured Funds
- Entity type: Other
 - Funding type: Equity investment;
 - Status: Open
 - 0 reviews 0 questions
 
- Usage: Scale-up;
 - Entity type: Public Agency
 - Total: 25B $
 - Funding type: Equity investment; Other;
 - Status: Open
 - Geographic focus: China; India; United States of America; North America; Europe; Asia;
 - 0 reviews 0 questions
 
- Usage: Go2Market;
 - Entity type: Public Agency
 - Total: 8B €
 - Funding type: Equity investment;
 - Status: Open
 - Geographic focus: Horizon Europe associated countries; Europe;
 - 0 reviews 0 questions
 
        Login or create an account. It's free and very fast
        
    


